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World Alzheimer Congress 2000
Washington, DC, July 9-18, 2000
The first ever global conference on Alzheimer’s dis-
ease, World Alzheimer Congress 2000, took place in
Washington, DC, USA, July 9-18, 2000. Nearly 5,000 of
the world’s leading Alzheimer researchers, physicians,
healthcare professionals, and other experts gathered for
almost ten days to discuss the latest information about
Alzheimer research, treatment and caregiving, and strat-
egies to eliminate the disease. Alzheimer’s disease affects
12 million people around the world. The number of
people with Alzheimer’s disease has been projected to in-
crease to 22 million by 2025, and to 45 million by 2050.
Alzheimer’s disease is today in focus as a fatal, degenera-
tive disease that attacks the brain and results in impaired
memory, thinking and behavior. As the disease progresses,
it becomes so severe that it interferes with an individual’s
daily functioning and eventually results in death.
Hosted by the Alzheimer’s Association (USA),
Alzheimer’s Disease International and Alzheimer Soci-
ety of Canada, World Alzheimer Congress 2000 united
four longstanding events with one program: Pivotal Re-
search (7th International Conference on Alzheimer’s Dis-
ease and Related Disorders), Bridging Research and Care
(a new program for physicians aimed at translating latest
research achievements to clinical practice), and Creative
Care (including 9th National Alzheimer’s Disease Edu-
cation Conference, 16th Alzheimer’s Disease Interna-
tional, and 22nd Alzheimer Society of Canada Confer-
ence).
During the Pivotal Research program, some 3,000
international researchers presented their studies on
Alzheimer’s disease and other neurodegenerative diseases.
Many of these studies offered encouraging news, includ-
ing promising results of human safety trials on an Al-
zheimer vaccine, favorable outcome of the phase III trial
of the drug memantine in people with moderate to severe
Alzheimer’s disease, and progress in creating better ani-
mal models of Alzheimer’s disease.
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Subjects of the program included new diagnostic and
diagnostic follow-up possibilities. Dr. Nick Fox from In-
stitute of Neurology, London, introduced studies with
registration of serial MR2 images of hippocampus, which
enables correlation with cognitive decline assessed by
neuropsychological testing in early stages of Alzheimer’s
disease or in mild cognitive impairment. Magnetic reso-
nance spectroscopy is also a useful tool in the diagnosis
of Alzheimer’s disease, as shown by Dr. R. Gonzales from
Massachusetts General Hospital and Harvard Medical
School from Boston.
An interesting review of mild cognitive impairment
was presented by Dr. R. Peterson (Mayo Clinic, Roches-
ter, Minnesota). Dr. J. Cummings from UCLA discussed
the importance of focusing onto behavioral disturbances
in advanced stages of the disease as well as on therapeu-
tic possibilities of previously introduced cholinesterase
inhibitors in the prevention and therapy of neuropsychi-
atric symptoms of Alzheimer’s disease.
The second part of the Congress, Bridging Research
and Care, primarily addressed physicians. All important
issues of Alzheimer’s disease were covered in-depth: defi-
nitions, diagnosis and therapy of Alzheimer’s and related
dementias (including vascular dementia, dementia asso-
ciated with Lewy bodies, and frontotemporal dementia).
Disclosing the diagnosis to family members, ethical and
end-of-life issues were discussed in the light of different
healthcare systems and different cultures throughout the
world.
During the third part of the Congress (Creative Care),
1,500 professional Alzheimer’s Association staff and vol-
unteers from all over the world, and family caregivers
shared information on diverse care approaches and hands-
on care techniques from various parts of the world. The
program included educational sessions for both family
caregivers, professional care providers, public policy mak-
ers, researchers, and staff from Alzheimer organizations
worldwide.
Despite the very intense program of the World Al-
zheimer Congress 2000, additional social events were
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organized as well. During the reception at the National
Museum of American History, the participants of the
Congress had an opportunity to gather informally and to
explore the Museum’s rich exhibition while welcomed by
‘George Washington’, ‘Abraham Lincoln’, and other per-
sons from the American history. Another festive occasion
was Municipal reception and dinner that took place at the
National Building Museum.
The Congress logo, ‘With change in mind’, is maybe
best explained by the words of Edward Truschke, presi-
dent of the American Alzheimer’s Association: “While
the pace of Alzheimer research is accelerating and there
are many promising findings, we are still in a race against
time as people from around the world live longer and face
a greater risk of getting this disease. We can keep
Alzheimer’s from becoming the epidemic of the new cen-
tury and we will defeat it. But only if we continue to work
together”.
Irena MartiniÊ-PopoviÊ
5th Congress of the European Federation of Neuro-
logical Societies
Copenhagen, October 14-18, 2000
Fifth Congress of the European Federation of Neu-
rological Societies was held in Bella Congress Center in
Copenhagen, Denmark, October 14-18, 2000. Approxi-
mately 2,200 neurologists from all over Europe as well as
those from North and South America, Africa, Asia and
Australia participated in the work of the Congress.
Copenhagen was probably chosen as the venue of the
Congress because this year the Danish Neurological So-
ciety is celebrating its 100th anniversary.
The main topics of the Congress were: Stroke, Head-
ache, Epilepsy, Movement Disorders, and Dementias.
Besides these main topics, many short communications,
focused workshops, teaching courses, special lectures, sat-
ellite symposia, scientist panel meetings, business meet-
ings, and other meetings took place during the Congress.
Within the main topic of Stroke, the most debated
subject was thrombolysis. Thrombolysis with recombinant
tissue plasminogen activator (rt-PA) has been used in ever
more European countries in therapy of ischemic stroke;
in some of them experimentally, while some countries
(e.g., Germany) have already registered rt-PA for therapy
of ischemic stroke. Therapeutic window for use of throm-
bolysis is 3 hours from the onset of symptoms. In this
short period of time, the patient has to be transported to
the hospital and complete diagnostic work-up carried out
including brain CT scan. It is not allowed to start throm-
bolytic therapy without brain CT scan. CT is needed to
rule out hemorrhagic stroke, and should be normal or may
show early signs of brain tissue ischemic lesion. Ischemia
should not involve more than one third of the middle
cerebral artery territory.
In Parkinson’s disease, the main discussion was about
the therapeutic role of COMT (catechol-O-methyl trans-
ferase) inhibitors. Also, some latest dopaminergic agonists
were introduced. Therapeutic approach to multiple scle-
rosis is still concentrated on beta interferons and immu-
nosuppressive therapy. Therapy of migraine has been en-
riched with a variety of new triptans.
The Congress was very well organized. Congress par-
ticipants were accommodated at various hotels in Copen-
hagen, with very convenient transfer from the hotels to
the Bella Congress Center.
Numerous posters, exactly 2,149 of them, were daily
presented. Posters were also divided according to topics,
and were displayed in three different poster sessions. Each
session took one day (Monday, Tuesday and Wednesday).
Each poster session chairperson discussed the poster topic
with the author and group of participants, and selected
one poster for the best poster award.
The work of the Congress was accompanied by a very
interesting social program. For reception at the City Hall,
organized by the Mayor of Copenhagen, only 500 seats
were available, while all other participants had a welcome
party at the Bella Congress Center. The participants had
an opportunity to enjoy in the ballet Giselle at the Royal
Danish Theatre. A farewell party was organized on the last
evening of the Congress, however, the attendance was less
than expected because the respective fee was not included
in the registration fee.
Some fifteen neurologists from Croatia, coming from
Zagreb, Rijeka, Osijek and Split, took part in the 5th
Congress of the European Federation of Neurological
Societies.
Zlatko Trkanjec
Sestre milosrdnice University hospital: The thir-
tieth Anniversary of the Center for Cardiac Pacing
In occasion of the 30th anniversary, the Center for
Cardiac Pacing at the Sestre milosrdnice University Hos-
pital was organized the 1th Croatian Symposium on Car-
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diac Pacing, entitled Cardiac Pacing: Art in the Present,
Challenge in the Future, in Hotel Inter-Continental in
Zagreb, on September 17, 2000.
Cardiac pacing is certainly one of the most efficacy
mode of therapy in the modern medicine, because it
makes possibly to the patients a survival, that is not dif-
ferent from the survival in the general population. Ow-
ing to continual technological progress, the present indi-
cations for cardiac pacing are not only therapeutic, but
preventive and haemodynamic. On the other hand, the
use of the implantable cardioverter-defibrillators has re-
duced significantly a mortality of patients proned to the
risk of sudden cardiac death and these devices have be-
come the first choice of therapy for life-threatening ven-
tricular tachyarrythmias.
In this fielding of the medicine, the Sestre milosrdnice
University Hospital was always in the same level as the
other developed European countries. The first pacemaker
was implanted in this University Hospital by Professor
Oberhofer in 1969, but the organized pacemaker’s im-
plantation was started in 1970. Since that about 4000
pacemakers were implanted at the Sestre milosrdnice
University Hospital (Figure 1). The purpose of the Sym-
posium was not only to demonstrate the long-term results
of the Center for Cardiac Pacing at the Sestre milosrdnice
University Hospital, but to bring up the present status of
cardiac and to point out the possibilities of its future de-
velopment. Promient Croatian and European cardiologist
were invited to the Symposium to expose this issue.
The Symposium was opened by Professor Zvonko
KusiÊ, head of the Sestre milosrdnice Hospital, Professor
©ime Mihatov, chief of the Department of Medicine at
the Sestre milosrdnice University Hospital, Professor
Vladimir Goldner, chairman of the Working Group on
Cardiac Pacing of the Croatian for Cardiac Pacing at the
Sestre milosrdnice University Hospital.
Structurally, the Symposium was divided into four
sessions. The two sessions were dedicated to fundamen-
tals of cardiac pacing. From classical indications to car-
diac pacin at transplanted heart, Dr. M. JakiÊ (Osijek), Dr.
J. GjuroviÊ (Zagreb), Ing. B. Ferek-PetriÊ (medtronic), Dr.
A. KuzmaniÊ (Split), Dr. B. BuljeviÊ (Zagreb), Dr. M.
LovriÊ-BenËiÊ (Zagreb), Dr. D. Hamel (Zagreb), Dr. R.
Ugljen (Krapinske Toplice), Dr. D. »uruvija (Rijeka) and
Dr. B. BioËina (Zagreb) presented the most important
clinical, technical and surgical aspects of cardiac pacing.
Modern pacemakers have been enriched with new algo-
rithms and functions. They have increased diagnostic ca-
pabilities and incorporate a variety of sensors n order that
pacing today may be as physiological, effective and safe
as possible. Also, lead technology has improved signifi-
cantly so as to ensure lower chronic pacing thresholds,
while single pass leads for VDD pacing allow chronic
sensing of atrial electrical activity with great reliability.
The session on Cardiac Pacing in Special Circum-
stances was specially interesting, because the experience
with a pacemaker therapy in hypertrophic cardiomyopa-
thy, dilated cardiomy opathy, vasovagal syncope and con-
gestive heart failure still smahll. In this session the
paperere presented by Dr. Z. BatiniË (Krapinske
Toplice), Dr. K. StaniÊ (Rijeka), Dr. D. Kosi (Zagreb),
Dr. A. JoviÊ (Zadar) and Dr. V. Goldner (Zagreb). Dual
chamber cardiac pacing with an appropriate atrioven-
tricular delay may be useful in patients with drug refrac-
tory hypertrophic obstructive cardiomyopathy, reducing
the pressure gradient in the left ventricle outflow tract
and attenuating symptoms, normal interatrial conduc-
tion and PR interval > 200 msec, could represent the
group getting real benefit from conventional dual-cham-
ber pacing with personalized atrioventricular interval,
computed by a pacemaker incorporating haemodynamic
monitoring parameter. Dual-chamber pacing, cerefully
prescribed on the basis of tilt-tableest results, may be ef-
fective in reducing symptoms if the patient with vasova-
gal syncope has a significant cardioninhibitory compo-
nent to the cause of its cause of its symptoms. The biven-
tricular pacing is a new therapeutic approach for the
patients with dilated cardiomyopathy unresponsive to
the best medical therapy, independently of the etioloy
(ischemic of idiopathic) in functional class III and IV.
with ejection fraction less thah 35% and left bundle
branch block longer than 150 msec.
The last session on Treatment of Tachycarrhytmias
was dedicated to therapy with implantable devices, includ-
ing atrial pacing (Dr. B. RadiÊ, Zagreb), atrial defi-
brillators (Dr. D. PetraË, Zagreb) and cardioverter-
defibrillators (Dr. J. Borobla, Budapest, and Dr R.
Cappato, Milan). Atrial pacing is indicated in patients
with sick sinus syndrome, while dual site atrial pacing is
superior to single site atrial ventricular defibrillaltor may
be taken into consideration in patients with atrial
tachyarrhytmias who otherwise have an indication for
vntricular cardioverter-defibrillator. Up to now there is
enough evidence, that implantable cardioverter-defibri-
llators are superior to antiarrhythimic drugs in reducing
mortality in patients who survived cardiac arrest or un-
stable ventricular tachycardia, or who have MADIT cri-
teria. At the end of the Symposium, Dr. D. PetraË sum-
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